Drug Discovery Services

Drug Discovery

DormaTarg offers the experience of biochemists and cancer cell biologists to develop relevant high-throughput microplate bioassays for lead compound identification. We also offer libraries of drug-like molecules with highly diverse structures as well as in silico screening technologies based on known pharmacophores and crystallized drug targets.

Services

News

  • Nov. 1, 2011 - DormaTarg awarded SBIR Phase II Grant for $2MM

  • Dec. 3, 2010 - DormaTarg awarded OCAST R&D Intern Partnerships Grant for $47,000

  • Dec. 2, 2010 - Dr. Ihnat awarded OARS Grant for $91,570